What's new

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion

Apr 11, 2025 - 14:01
 0
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion
Read More

Tags:

Previous Article

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8...

Next Article

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva ...

Related Posts

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 17, 2025  0

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

ICH M11 guideline, clinical study protocol template and technical specifications - Scientific guideline

ICH M11 guideline, clinical study protocol template and...

Mar 18, 2025  0